QIAGEN acquires AmniSure International to add unique assay to emerging Point of Need portfolio
04-May-2012
- USA
Financial terms of the agreement to acquire AmniSure, a privately held company, were not disclosed.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.